Auf dieser Seite
IART Integra LifeSciences Holdings Corporation - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 29, 2026
$12,68
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$8,7052-Wochen-Tief
$20,4952-Wochen-Hoch
P/E (TTM)
-126.8
EPS (TTM)
$-0.10
Umsatz (TTM)
$1.65B
Ihre Abzeichen
52W-Spanne
$9–$20
Analystenbewertung
HOLD
Kursziel
$20
P/E
-126.8
ROE
-0.70%
Nettogewinnmarge
-0.44%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
IART Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$12.68
P/E (TTM)
-126.8
EPS (TTM)
$-0.10
Umsatz (TTM)
$1.65B
ROE (TTM)
-0.70%
52W-Spanne
$9–$20
IART Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 4. Januar 2017 | 2-for-1 | Vorwärts |
| 26. Mai 1998 | 1-for-2 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$1.64B2016-12-31 → 2025-12-31
EPS$-6.742016-12-31 → 2025-12-31
Freier Cashflow$-31M2016-12-31 → 2025-12-31
Nettogewinnmarge-0.44%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | IART | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -126.85-Jahres-Durchschnitt ≈-28.4 | ≈-28.4 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | IART | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 4.0%5-Jahres-Durchschnitt ≈1.4% | ≈1.4% | 1.9% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -30.2%5-Jahres-Durchschnitt ≈1.4% | ≈1.4% | 1.9% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -0.01%5-Jahres-Durchschnitt ≈-0.54% | ≈-0.54% | 1.1% | Im Einklang | |
| Nettogewinnmarge (TTM) | -0.44%5-Jahres-Durchschnitt ≈-1.0% | ≈-1.0% | -3.6% | Spitzenklasse | |
| ROA (TTM) | -0.20%5-Jahres-Durchschnitt ≈-0.53% | ≈-0.53% | -6.7% | Unterdurchschnittlich | |
| ROE (TTM) | -0.70%5-Jahres-Durchschnitt ≈-5.1% | ≈-5.1% | -12.3% | Schwach | |
| ROIC | -43.3%5-Jahres-Durchschnitt ≈-3.3% | ≈-3.3% | 0.08% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | IART | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 3.65-Jahres-Durchschnitt ≈2.8 | ≈2.8 | 3.3 | Im Einklang | |
| Quick Ratio (MRQ) | 1.65-Jahres-Durchschnitt ≈1.6 | ≈1.6 | 1.6 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | IART | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 1.5%5-Jahres-Durchschnitt ≈3.7% | ≈3.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 1.6%5-Jahres-Durchschnitt ≈2.3% | ≈2.3% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 3.6% | · | · | · | |
| EPS YoY (EPS VjV) | -61.1%5-Jahres-Durchschnitt ≈-8.6% | ≈-8.6% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -62.5%5-Jahres-Durchschnitt ≈-9.8% | ≈-9.8% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -18.8% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -20.3% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | IART | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.45-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.6 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 1.75-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 1.8 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 5.95-Jahres-Durchschnitt ≈6.2 | ≈6.2 | 6.4 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$369.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
10.5%
Nächster Bericht
Okt 28, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 29, 2026 | $0.56 | $0.49 | 13.6% |
| 31. März 2026 | $0.54 | $0.41 | 30.9% | |
| 31. Dezember 2025 | $0.83 | $0.82 | 1.7% | |
| 30. September 2025 | $0.54 | $0.44 | 21.7% | |
| 30. Juni 2025 | $0.45 | $0.44 | 2.2% | |
| 31. März 2025 | $0.41 | $0.44 | -6.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.64B | $1.61B | $1.54B | $1.56B | $1.54B | $1.37B | $1.52B | $1.47B | $1.19B | $992M | $883M | $797M | |
| Cost of Revenue | $804M | $728M | $657M | $587M | $598M | $521M | $565M | $571M | $436M | $349M | $327M | $303M | |
| Gross Profit | · | · | · | · | · | $851M | $953M | $901M | $753M | $643M | $556M | $494M | |
| R&D Expense | · | · | · | · | · | · | · | $78M | $63M | $58M | $51M | $44M | |
| SG&A Expense | $700M | $717M | $657M | $616M | $637M | $595M | $688M | $691M | $624M | $456M | $416M | $376M | |
| Operating Expenses | $2.13B | $1.58B | $1.43B | $1.32B | $1.35B | $1.22B | $1.42B | $1.36B | $1.14B | $877M | $803M | $729M | |
| Operating Income | $-493M | $28M | $112M | $239M | $197M | $151M | $94M | $111M | $45M | $115M | $80M | $68M | |
| Interest Expense | · | · | $51M | $50M | $50M | $72M | $54M | $65M | $35M | $26M | $24M | $22M | |
| Interest Income | $18M | $20M | $17M | $12M | $7M | $9M | $11M | $3M | $255.0K | $24.0K | $30.0K | $168.0K | |
| Other Non-op | $-2M | $4M | $4M | $12M | $19M | $4M | $10M | $8M | $1M | $845.0K | $5M | $-492.0K | |
| Pretax Income | $-564M | $-18M | $81M | $214M | $215M | $94M | $60M | $57M | $11M | $90M | $61M | $46M | |
| Income Tax | $-47M | $-11M | $13M | $33M | $46M | $-40M | $10M | $-3M | $-53M | $16M | $54M | $9M | |
| Net Income | $-516M | $-7M | $68M | $181M | $169M | $134M | $50M | $61M | $65M | $75M | $-4M | $34M | |
| EPS (Basic) | $-6.74 | $-0.09 | $0.85 | $2.18 | $2.00 | $1.58 | $0.59 | $0.73 | $0.84 | $1.00 | $-0.05 | $0.52 | |
| EPS (Diluted) | $-6.74 | $-0.09 | $0.84 | $2.16 | $1.98 | $1.57 | $0.58 | $0.72 | $0.82 | $0.94 | $-0.05 | $0.52 | |
| Shares (Basic) | 76,672,000 | 77,010,000 | 80,089,000 | 82,997,000 | 84,698,000 | 84,650,000 | 85,637,000 | 82,857,000 | 76,897,000 | 74,386,000 | 68,990,000 | 64,864,000 | |
| Shares (Diluted) | 76,672,000 | 77,010,000 | 80,337,000 | 83,516,000 | 85,485,000 | 85,228,000 | 86,494,000 | 83,999,000 | 79,121,000 | 79,194,000 | 71,354,000 | 65,920,000 | |
| EBITDA | $-493M | $28M | $112M | $239M | $197M | $151M | $203M | $222M | $134M | $188M | $138M | $127M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $235M | $246M | $276M | $457M | $513M | $470M | $199M | $139M | $175M | $102M | $48M | $72M | |
| Short-term Investments | $29M | $27M | $33M | $0 | · | · | · | · | · | $0 | · | · | |
| Receivables | $279M | $272M | $259M | $263M | $232M | $226M | $275M | $266M | $252M | $148M | $132M | $110M | |
| Inventory | $493M | $429M | $390M | $325M | $317M | $310M | $316M | $280M | $296M | $217M | $211M | $189M | |
| Prepaid Expense | $96M | $77M | $67M | $86M | $91M | $69M | $68M | $90M | $99M | $28M | $43M | $28M | |
| Other Current Assets | $28M | $30M | $33M | $31M | · | · | · | · | · | · | · | · | |
| Current Assets | $1.16B | $1.08B | $1.06B | $1.16B | $1.15B | $1.24B | $858M | $775M | $822M | $495M | $438M | $529M | |
| PP&E (Net) | $444M | $406M | $340M | $311M | $312M | $288M | $337M | $300M | $269M | $222M | $205M | $194M | |
| PP&E (Gross) | $888M | $803M | $708M | $641M | $627M | $570M | $622M | $555M | $489M | $413M | $374M | $341M | |
| Accum. Depreciation | $444M | $397M | $367M | $330M | $315M | $283M | $285M | $255M | $220M | $191M | $169M | $147M | |
| Goodwill | $615M | $1.10B | $1.06B | $1.04B | $1.01B | $932M | $954M | $926M | $938M | $511M | $512M | $363M | |
| Intangibles | $1.13B | $1.21B | $1.07B | $1.13B | $1.15B | $989M | $1.03B | $1.08B | $1.16B | $561M | $604M | $413M | |
| Other Non-current Assets | $38M | $67M | $58M | $57M | $16M | $11M | $15M | $20M | $16M | $12M | $7M | $10M | |
| Total Assets | $3.60B | $4.04B | $3.78B | $3.89B | $3.78B | $3.62B | $3.30B | $3.11B | $3.21B | $1.81B | $1.77B | $1.59B | |
| Accrued Liabilities | $130M | $122M | $101M | $80M | $120M | $94M | $77M | $85M | $88M | $35M | $39M | $40M | |
| Current Liabilities | $456M | $922M | $307M | $321M | $340M | $401M | $331M | $263M | $349M | $124M | $139M | $126M | |
| Capital Leases | $163M | $167M | $167M | $157M | $90M | $88M | $98M | · | · | · | · | · | |
| Deferred Tax | $6M | $61M | $35M | $63M | $46M | $16M | $37M | $58M | $65M | $149M | $155M | $100M | |
| Other Non-current Liabilities | $204M | $146M | $200M | $139M | $120M | $187M | $118M | $80M | $54M | $31M | $29M | $28M | |
| Total Liabilities | $2.56B | $2.49B | $2.19B | $2.09B | $2.10B | $2.10B | $1.89B | $1.73B | $2.25B | $968M | $1.02B | $883M | |
| Long-term Debt | $727M | $760M | $775M | $775M | $844M | $878M | $878M | $900M | · | · | · | · | |
| Common Stock | $923.0K | $916.0K | $909.0K | $905.0K | $896.0K | $893.0K | $887.0K | $880.0K | $813.0K | $777.0K | $917.0K | $416.0K | |
| Retained Earnings | $423M | $940M | $947M | $879M | $699M | $532M | $399M | $348M | $285M | $220M | $146M | $315M | |
| Treasury Stock | $689M | $691M | $647M | $363M | $234M | $235M | $120M | $121M | $122M | $123M | $367M | $367M | |
| AOCI | $-30M | $-28M | $-15M | $10M | $-45M | $-74M | $-76M | $-45M | $-24M | $-57M | $-48M | $-23M | |
| Stockholders' Equity | $1.04B | $1.55B | $1.59B | $1.80B | $1.68B | $1.51B | $1.42B | $1.38B | $962M | $840M | $751M | $704M | |
| Liabilities + Equity | $3.60B | $4.04B | $3.78B | $3.89B | $3.78B | $3.62B | $3.30B | $3.11B | $3.21B | $1.81B | $1.77B | $1.59B | |
| Shares Outstanding | · | · | · | · | 89,600,000 | 89,251,000 | · | · | · | · | · | · |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $109M | $111M | $89M | $73M | $59M | $46M | |
| Stock-based Comp | $19M | $24M | $20M | $28M | $36M | $20M | $21M | $21M | $22M | $17M | $15M | $15M | |
| Deferred Tax | $-66M | $-21M | $-12M | $-5M | $-3M | $-64M | $-19M | $-8M | $-67M | $-6M | $-351.0K | $-7M | |
| Amort. of Intangibles | $15M | $21M | $12M | $14M | $17M | $28M | $27M | $21M | $20M | $14M | $10M | $7M | |
| Other Non-cash | · | · | · | · | · | · | $70M | $16M | $7M | $-42M | $24M | $-30M | |
| Operating Cash Flow | $50M | $129M | $140M | $264M | $312M | $204M | $231M | $200M | $115M | $116M | $105M | $84M | |
| CapEx | $81M | $104M | $67M | $42M | $48M | $39M | $70M | $78M | $44M | $47M | $33M | $38M | |
| Investing Cash Flow | $-108M | $-391M | $-94M | $-59M | $-161M | $-68M | $-163M | $-50M | $-1.22B | $-43M | $-372M | $-363M | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $350M | $0 | $0 | $220M | $0 | |
| Stock Repurchased | $221.0K | $52M | $275M | $125M | $0 | $100M | $0 | $0 | · | · | · | · | |
| Net Stock Activity | $-221.0K | $-52M | $-275M | $-125M | $0 | $-100M | $0 | $350M | $0 | $0 | $220M | $0 | |
| Financing Cash Flow | $28M | $238M | $-230M | $-252M | $-98M | $122M | $-9M | $-181M | $1.17B | $-15M | $248M | $239M | |
| Net Change in Cash | $-11M | $-30M | $-180M | $-57M | $43M | $271M | $60M | $-36M | $73M | $54M | $-24M | $-49M | |
| Taxes Paid | $17M | $23M | $24M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-31M | $25M | $73M | $222M | $264M | $165M | $162M | $122M | $71M | $69M | $61M | $38M | |
| Levered FCF | · | · | $30M | $180M | $225M | $62M | $117M | $53M | $-128M | $48M | $58M | $20M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 62.0% | 62.8% | 61.2% | 63.3% | 64.8% | 63.0% | · | |
| Operating Margin | -30.2% | 1.8% | 7.2% | 15.3% | 12.8% | 11.0% | 6.2% | 7.5% | 3.8% | 11.6% | 9.0% | 7.1% | |
| Net Margin | -31.6% | -0.43% | 4.4% | 11.6% | 11.0% | 9.8% | 3.3% | 4.1% | 5.5% | 7.5% | -0.40% | 3.7% | |
| Pretax Margin | -34.5% | -1.1% | 5.3% | 13.7% | 13.9% | 6.8% | 4.0% | 3.9% | 0.96% | 9.1% | 6.9% | 4.6% | |
| EBITDA Margin | -30.2% | 1.8% | 7.2% | 15.3% | 12.8% | 11.0% | 13.4% | 15.1% | 11.3% | 18.9% | 15.7% | 13.7% | |
| ROA | -13.5% | -0.18% | 1.8% | 4.7% | 4.6% | 3.9% | 1.6% | 1.9% | 2.6% | 4.2% | -0.21% | 2.5% | |
| ROE | -49.6% | -0.45% | 4.3% | 10.2% | 10.2% | 9.2% | 3.6% | 4.4% | 6.9% | 9.4% | -0.48% | 5.0% | |
| ROIC | -43.3% | 0.70% | 5.9% | 11.2% | 9.2% | 14.3% | 5.5% | 8.6% | 26.5% | 11.3% | 1.2% | 7.4% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 1.2 | 3.4 | 3.6 | 3.4 | 3.1 | 2.6 | 3.0 | 2.4 | 4.0 | 3.2 | 4.2 | |
| Quick Ratio | 1.2 | 0.6 | 1.9 | 2.2 | 2.2 | 1.7 | 1.4 | 1.5 | 1.2 | 2.0 | 1.3 | 1.6 | |
| Interest Coverage | · | · | 2.2 | 4.8 | 3.9 | 2.1 | 1.7 | 1.7 | 1.3 | 4.5 | 3.4 | 3.0 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | 0.7 | |
| Inventory Turnover | 1.7 | 1.8 | 1.8 | 1.8 | 1.9 | 1.7 | 1.9 | 2.0 | 1.7 | 1.6 | 1.6 | 1.6 | |
| Receivables Turnover | 5.9 | 6.1 | 5.9 | 6.3 | 6.7 | 5.5 | 5.6 | 5.7 | 5.9 | 7.1 | 7.3 | 7.4 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $21.33 | $20.91 | $19.19 | $18.65 | $18.04 | $16.10 | $17.55 | $17.53 | $15.02 | $12.53 | $24.74 | $28.16 | |
| Cash Flow / Share | $0.66 | $1.68 | $1.74 | $3.17 | $3.65 | $2.39 | $2.68 | $2.38 | $1.45 | $1.47 | $2.65 | $2.41 | |
| EPS (TTM) | $-6.74 | $-0.09 | $0.84 | $2.16 | $1.98 | $1.57 | $0.58 | $0.72 | $0.82 | $0.94 | $-0.05 | $0.52 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 1.5% | 4.5% | -1.0% | 0.99% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.6% | 1.5% | 4.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -61.1% | 9.1% | 26.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | -18.8% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -62.5% | 6.8% | 26.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | -20.3% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.64B | $1.61B | $1.54B | $1.56B | $1.54B | $1.37B | $1.52B | $1.47B | $1.19B | $992M | $883M | $797M | |
| Net Income TTM | $-516M | $-7M | $68M | $181M | $169M | $134M | $50M | $61M | $65M | $75M | $-4M | $34M | |
| P/E | -1.8 | -252.0 | 51.8 | 26.0 | 33.8 | 41.4 | 100.5 | 62.6 | 58.4 | 45.6 | -677.8 | 47.1 | |
| Earnings Yield | -54.3% | -0.40% | 1.9% | 3.9% | 3.0% | 2.4% | 1.0% | 1.6% | 1.7% | 2.2% | -0.15% | 2.1% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $419M | $392M | $435M | $402M | $416M | $383M | $443M | $381M | $418M | $369M | $397M | $382M | $381M | $381M | $398M | $385M | |
| Cost of Revenue | $199M | $175M | $214M | $195M | $206M | $188M | $194M | $181M | $192M | $162M | $171M | $164M | $174M | $148M | $148M | $148M | |
| SG&A Expense | $172M | $178M | $169M | $169M | $180M | $181M | $179M | $177M | $195M | $166M | $163M | $162M | $165M | $167M | $152M | $144M | |
| Operating Expenses | $399M | $380M | $412M | $390M | $928M | $398M | $407M | $389M | $421M | $365M | $361M | $356M | $369M | $344M | $330M | $320M | |
| Operating Income | $19M | $11M | $23M | $12M | $-513M | $-15M | $36M | $-8M | $-3M | $4M | $36M | $27M | $13M | $36M | $68M | $65M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $14M | · | $13M | $12M | $12M | · | $13M | |
| Interest Income | $4M | $4M | $4M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $5M | $3M | |
| Other Non-op | $4M | $4M | $581.0K | $-842.0K | $-2M | $-144.0K | $1M | $2M | $1M | $-610.0K | $2M | $471.0K | $-155.0K | $1M | $4M | $3M | |
| Pretax Income | $5M | $-2M | $4M | $-7M | $-531M | $-30M | $23M | $-20M | $-15M | $-5M | $29M | $19M | $4M | $30M | $64M | $59M | |
| Income Tax | $262.0K | $2M | $6M | $-1M | $-47M | $-5M | $3M | $-10M | $-3M | $-2M | $9M | $-888.0K | $-360.0K | $6M | $11M | $9M | |
| Net Income | $4M | $-5M | $-2M | $-5M | $-484M | $-25M | $19M | $-11M | $-12M | $-3M | $20M | $19M | $4M | $24M | $53M | $50M | |
| EPS (Basic) | $0.06 | $-0.06 | $-0.03 | $-0.07 | $-6.31 | $-0.33 | $0.25 | $-0.14 | $-0.16 | $-0.04 | $0.26 | $0.24 | $0.05 | $0.30 | $0.65 | $0.60 | |
| EPS (Diluted) | $0.06 | $-0.06 | $-0.03 | $-0.07 | $-6.31 | $-0.33 | $0.25 | $-0.14 | $-0.16 | $-0.04 | $0.26 | $0.24 | $0.05 | $0.29 | $0.63 | $0.60 | |
| Shares (Basic) | 77,293,000 | 76,951,000 | · | 76,753,000 | 76,695,000 | 76,463,000 | · | 76,448,000 | 77,409,000 | 77,735,000 | · | 79,690,000 | 80,966,000 | 81,871,000 | · | 83,042,000 | |
| Shares (Diluted) | 78,168,000 | 76,951,000 | · | 76,753,000 | 76,695,000 | 76,463,000 | · | 76,448,000 | 77,409,000 | 77,735,000 | · | 79,811,000 | 81,151,000 | 82,323,000 | · | 83,399,000 | |
| EBITDA | $19M | $11M | · | $12M | $-513M | $-15M | · | $-8M | $-3M | $4M | · | $27M | $13M | $36M | · | $65M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $214M | $237M | $235M | $232M | $218M | $239M | $246M | $215M | $215M | $592M | · | $274M | $309M | $307M | · | $512M | |
| Short-term Investments | $60M | $29M | $29M | $36M | $36M | $34M | $27M | $62M | $82M | $71M | · | · | · | · | · | · | |
| Receivables | $267M | $264M | $279M | $262M | $285M | $252M | $272M | $248M | $271M | $241M | · | $256M | $259M | $254M | · | $248M | |
| Inventory | $492M | $495M | $493M | $489M | $465M | $445M | $429M | $437M | $422M | $403M | · | $366M | $354M | $351M | · | $311M | |
| Prepaid Expense | $104M | $98M | $96M | $94M | $103M | $104M | $77M | $86M | $94M | $73M | · | $131M | $129M | $117M | · | $123M | |
| Other Current Assets | $54M | $49M | $28M | $30M | $36M | $32M | $30M | $50M | $29M | $35M | · | · | · | · | · | · | |
| Current Assets | $1.19B | $1.17B | $1.16B | $1.14B | $1.14B | $1.11B | $1.08B | $1.10B | $1.11B | $1.42B | · | $1.03B | $1.05B | $1.03B | · | $1.20B | |
| PP&E (Net) | $446M | $447M | $444M | $437M | $435M | $423M | $406M | $391M | $374M | $345M | · | $319M | $318M | $315M | · | $301M | |
| PP&E (Gross) | · | · | $888M | · | · | · | $803M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $444M | · | · | · | $397M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $611M | $613M | $615M | $615M | $616M | $1.11B | $1.10B | $1.12B | $1.10B | $1.04B | $1.06B | $1.04B | $1.04B | $1.04B | $1.04B | $978M | |
| Intangibles | $1.08B | $1.11B | $1.13B | $1.16B | $1.19B | $1.19B | $1.21B | $1.21B | $1.22B | $1.02B | · | $1.07B | $1.09B | $1.11B | · | $1.05B | |
| Other Non-current Assets | $32M | $35M | $38M | $42M | $46M | $53M | $67M | $54M | $71M | $68M | · | $78M | $67M | $56M | · | $78M | |
| Total Assets | $3.56B | $3.58B | $3.60B | $3.65B | $3.67B | $4.05B | $4.04B | $4.07B | $4.07B | $4.08B | · | $3.74B | $3.78B | $3.74B | · | $3.81B | |
| Accrued Liabilities | $108M | $133M | $130M | $133M | $131M | $137M | $122M | $132M | $102M | $112M | · | $90M | $95M | $93M | · | $79M | |
| Current Liabilities | $331M | $347M | $456M | $364M | $930M | $918M | $922M | $913M | $328M | $302M | · | $356M | $377M | $282M | · | $304M | |
| Capital Leases | $163M | $160M | $163M | $161M | $159M | $161M | $167M | $168M | $170M | $170M | · | $168M | $160M | $157M | · | $158M | |
| Deferred Tax | $3M | $6M | $6M | $58M | $60M | $58M | $61M | $69M | $87M | $31M | · | $74M | $71M | $62M | · | $70M | |
| Other Non-current Liabilities | $194M | $196M | $204M | $233M | $253M | $160M | $146M | $190M | $155M | $140M | · | $142M | $153M | $127M | · | $64M | |
| Total Liabilities | $2.52B | $2.54B | $2.56B | $2.61B | $2.63B | $2.53B | $2.49B | $2.54B | $2.54B | $2.48B | · | $2.16B | $2.09B | $2.07B | · | $2.08B | |
| Long-term Debt | $707M | $717M | $727M | $736M | $746M | $756M | · | $765M | $770M | $775M | · | $775M | $775M | $775M | · | $810M | |
| Common Stock | $921.0K | $922.0K | $923.0K | $923.0K | $923.0K | $921.0K | $916.0K | $916.0K | $916.0K | $915.0K | · | $909.0K | $909.0K | $908.0K | · | $903.0K | |
| Retained Earnings | $423M | $419M | $423M | $425M | $431M | $915M | $940M | $920M | $931M | $944M | · | $927M | $908M | $903M | · | $826M | |
| Treasury Stock | $687M | $687M | $689M | $690M | $690M | $690M | $691M | $692M | $681M | $646M | · | $613M | $514M | $482M | · | $363M | |
| AOCI | $-40M | $-31M | $-30M | $-32M | $-31M | $-24M | $-28M | $-25M | $-19M | $-11M | · | $2M | $5M | $7M | · | $-7M | |
| Stockholders' Equity | $1.04B | $1.04B | $1.04B | $1.04B | $1.04B | $1.52B | $1.55B | $1.52B | $1.53B | $1.60B | $1.59B | $1.58B | $1.68B | $1.67B | $1.80B | $1.72B | |
| Liabilities + Equity | $3.56B | $3.58B | $3.60B | $3.65B | $3.67B | $4.05B | $4.04B | $4.07B | $4.07B | $4.08B | · | $3.74B | $3.78B | $3.74B | · | $3.81B | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 90,341,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $5M | $6M | $6M | $5M | $2M | $7M | $4M | $7M | $6M | $6M | $5M | $5M | $4M | $6M | $9M | |
| Deferred Tax | $-4M | $1M | $-11M | $-9M | $-45M | $-2M | $-7M | $-9M | $-2M | $-3M | $-15M | $1M | $-227.0K | $2M | $-6M | $-6M | |
| Amort. of Intangibles | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $10M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Operating Cash Flow | $23M | $10M | $12M | $41M | $9M | $-11M | $51M | $22M | $40M | $16M | $59M | $27M | $28M | $26M | $85M | $68M | |
| CapEx | $12M | $15M | $17M | $15M | $20M | $29M | $30M | $30M | $30M | $15M | $25M | $13M | $16M | $14M | $14M | $9M | |
| Investing Cash Flow | $-43M | $-15M | $-35M | $-16M | $-22M | $-36M | $-4M | $-10M | $-322M | $-54M | $-57M | $-8M | $-16M | $-14M | $-55M | $15M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $2M | $0 | $50M | $0 | $0 | $125M | $0 | $150M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-150M | · | · | |
| Financing Cash Flow | $-818.0K | $8M | $24M | $-10M | $-21M | $35M | $-7M | $-20M | $-94M | $359M | $-7M | $-50M | $-11M | $-163M | $-98M | $-8M | |
| Net Change in Cash | $-22M | $2M | $3M | $14M | $-21M | $-7M | $31M | $-79.0K | $-377M | $316M | $3M | $-35M | $2M | $-149M | $-55M | $65M | |
| Free Cash Flow | · | $-5M | · | · | · | $-40M | · | · | · | $291.0K | · | · | · | $12M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | $3M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.6% | 2.9% | · | 2.9% | -123.4% | -4.0% | · | -2.1% | -0.72% | 1.1% | · | 7.0% | 3.3% | 9.6% | · | 16.9% | |
| Net Margin | 1.1% | -1.2% | · | -1.3% | -116.5% | -6.6% | · | -2.8% | -3.0% | -0.89% | · | 5.1% | 1.1% | 6.4% | · | 13.0% | |
| Pretax Margin | 1.1% | -0.61% | · | -1.7% | -127.8% | -7.8% | · | -5.3% | -3.6% | -1.4% | · | 4.9% | 1.0% | 7.8% | · | 15.3% | |
| EBITDA Margin | 4.6% | 2.9% | · | 2.9% | -123.4% | -4.0% | · | -2.1% | -0.72% | 1.1% | · | 7.0% | 3.3% | 9.6% | · | 16.9% | |
| ROA | 0.12% | -0.12% | · | -0.14% | -12.5% | -0.62% | · | -0.27% | -0.32% | -0.08% | · | 0.52% | 0.11% | 0.65% | · | 1.3% | |
| ROE | 0.43% | -0.36% | · | -0.42% | -37.6% | -1.6% | · | -0.69% | -0.77% | -0.20% | · | 1.2% | 0.25% | 1.5% | · | 3.0% | |
| ROIC | 1.8% | 2.1% | · | 0.90% | -45.0% | -0.86% | · | -0.28% | -0.16% | 0.16% | · | 1.8% | 0.81% | 1.8% | · | 3.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 3.4 | · | 3.1 | 1.2 | 1.2 | · | 1.2 | 3.4 | 4.7 | · | 2.9 | 2.8 | 3.6 | · | 3.9 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.5 | 0.6 | 0.6 | · | 0.6 | 1.7 | 3.0 | · | 1.5 | 1.5 | 2.0 | · | 2.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 0.3 | · | 2.0 | 1.0 | 3.0 | · | 5.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.5 | |
| Receivables Turnover | 1.5 | 1.5 | · | 1.6 | 1.5 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.6 | · | 1.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $19.09 | |
| Revenue / Share | $5.36 | $5.09 | · | $5.24 | $5.42 | $5.00 | · | $4.98 | $5.40 | $4.75 | · | $4.79 | $4.70 | $4.63 | · | $4.62 | |
| Cash Flow / Share | · | $0.13 | · | · | · | $-0.15 | · | · | · | $0.20 | · | · | · | $0.32 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5.67 | |
| EPS (TTM) | $-0.10 | $-6.47 | · | $-6.46 | $-6.53 | $-0.38 | · | $-0.08 | $0.30 | $0.51 | · | $1.21 | $1.57 | $2.06 | · | $2.06 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.65B | $1.64B | · | $1.64B | $1.62B | $1.62B | · | $1.56B | $1.57B | $1.53B | · | $1.54B | $1.55B | $1.56B | · | $1.57B | |
| Net Income TTM | $-7M | $-496M | · | $-495M | $-501M | $-29M | · | $-7M | $24M | $40M | · | $101M | $131M | $172M | · | $173M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.83B | |
| P/E | -179.6 | -1.5 | · | -2.2 | -1.9 | -57.9 | · | -227.1 | 97.1 | 69.5 | · | 31.6 | 26.2 | 27.9 | · | 20.6 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.2 | |
| Earnings Yield | -0.56% | -68.7% | · | -45.1% | -53.2% | -1.7% | · | -0.44% | 1.0% | 1.4% | · | 3.2% | 3.8% | 3.6% | · | 4.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $1.64B | $1.61B | $1.54B | $1.56B | $1.54B |
| Betriebsgewinnmarge % | -30.2% | 1.8% | 7.2% | 15.3% | 12.8% |
| Nettoergebnis | $-516M | $-7M | $68M | $181M | $169M |
| Verwässerte EPS | $-6.74 | $-0.09 | $0.84 | $2.16 | $1.98 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.5 | 1.2 | 3.4 | 3.6 | 3.4 |
| Quick Ratio | 1.2 | 0.6 | 1.9 | 2.2 | 2.2 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-31M | $25M | $73M | $222M | $264M |
Institutionelle Eigentümer (13F) 222 Einreicher · $1.4B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
222
Gehaltener Wert
$1.4B
Neue Positionen
42
Geschlossene Positionen
31
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 42 (+3 vs. Vorquartal) | 31 (+2 vs. Vorquartal) | 73 (+13 vs. Vorquartal) | 59 (-8 vs. Vorquartal) | +1.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $191.886.488 | 10.684.103 | 13,49% | Aktien |
| Rubric Capital Management LP | $139.260.655 | 7.753.934 | 9,79% | Aktien |
| VANGUARD GROUP INC | $89.555.950 | 7.210.624 | 6,30% | Aktien |
| Invesco Ltd. | $67.338.631 | 3.749.367 | 4,73% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $67.225.950 | 3.743.093 | 4,73% | Aktien |
| MORGAN STANLEY | $64.531.722 | 3.593.079 | 4,54% | Aktien |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $61.766.200 | 3.439.098 | 4,34% | Aktien |
| FULLER & THALER ASSET MANAGEMENT, INC. | $61.710.664 | 3.436.006 | 4,34% | Aktien |
| STATE STREET CORP | $52.925.642 | 2.946.862 | 3,72% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $52.913.267 | 2.946.173 | 3,72% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $42.626.533 | 2.364.777 | 3,00% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $39.814.517 | 2.216.653 | 2,80% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $32.183.715 | 1.791.635 | 2,26% | Aktien |
| GOLDMAN SACHS GROUP INC | $26.467.994 | 1.473.719 | 1,86% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $26.241.429 | 1.461.104 | 1,85% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $25.857.856 | 1.439.747 | 1,82% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.170.509 | 1.401.476 | 1,77% | Aktien |
| BANK OF AMERICA CORP /DE/ | $23.873.348 | 1.329.251 | 1,68% | Aktien |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $18.377.461 | 1.023.243 | 1,29% | Aktien |
| Allianz Asset Management GmbH | $18.053.446 | 1.005.203 | 1,27% | Aktien |
| GLENMEDE TRUST CO NA | $17.028.630 | 948.142 | 1,20% | Aktien |
| NORTHERN TRUST CORP | $14.880.435 | 828.532 | 1,05% | Aktien |
| Glenmede Investment Management, LP | $12.072.021 | 842.430 | 0,85% | Aktien |
| Balyasny Asset Management L.P. | $11.506.361 | 640.666 | 0,81% | Aktien |
| Quantinno Capital Management LP | $10.940.011 | 609.132 | 0,77% | Aktien |
| Kent Lake PR LLC | $10.777.392 | 752.086 | 0,76% | Aktien |
| Invenomic Capital Management LP | $10.399.487 | 579.036 | 0,73% | Aktien |
| Integral Health Asset Management, LLC | $9.878.000 | 550.000 | 0,69% | Aktien |
| D. E. Shaw & Co., Inc. | $9.110.246 | 507.252 | 0,64% | Aktien |
| Bank of New York Mellon Corp | $8.722.669 | 485.672 | 0,61% | Aktien |
| Nuveen, LLC | $8.718.826 | 485.458 | 0,61% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $7.952.311 | 442.779 | 0,56% | Aktien |
| DEUTSCHE BANK AG\ | $7.819.048 | 435.359 | 0,55% | Aktien |
| Access Investment Management LLC | $7.273.836 | 405.002 | 0,51% | Aktien |
| Leeward Investments, LLC - MA | $6.288.730 | 350.152 | 0,44% | Aktien |
| MARSHALL WACE, LLP | $6.281.277 | 349.737 | 0,44% | Aktien |
| PFM Health Sciences, LP | $6.263.478 | 348.746 | 0,44% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $5.982.476 | 333.100 | 0,42% | Aktien |
| Legal & General Group Plc | $5.918.700 | 329.549 | 0,42% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $5.807.958 | 323.383 | 0,41% | Aktien |
| KOTLER KEVIN | $5.308.867 | 427.445 | 0,37% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $4.929.319 | 274.461 | 0,35% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $4.636.535 | 258.159 | 0,33% | Aktien |
| FRANKLIN RESOURCES INC | $4.141.180 | 230.578 | 0,29% | Aktien |
| Public Sector Pension Investment Board | $4.128.788 | 229.888 | 0,29% | Aktien |
| JPMORGAN CHASE & CO | $4.019.805 | 214.504 | 0,28% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $3.321.792 | 184.955 | 0,23% | Aktien |
| RHUMBLINE ADVISERS | $3.075.898 | 171.265 | 0,22% | Aktien |
| Vanguard Global Advisers, LLC | $3.018.968 | 168.094 | 0,21% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $2.736.583 | 152.371 | 0,19% | Aktien |
Aktivisten & 5%+-Eigentümer 9 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Stuart M. Essig ×5 Einreichungen | 11. Mai 2015 | · | Erste Einreichung | · | SEC |
| Stuart M. Essig (2) | 29. Oktober 2012 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 4. Januar 2008 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 19. Juni 2007 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 6. Dezember 2006 | · | Erste Einreichung | · | SEC |
| QUANTUM INDUSTRIAL PARTNERS LDC, QIH MANAGEMENT INVESTOR, L.P., QIH MANAGEMENT LLC, SOROS FUND MANAGEMENT LLC, GEORGE SOROS (in the capacity described herein) ×10 Einreichungen | 4. April 2006 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 31. Januar 2006 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 4. Januar 2006 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 14. November 2005 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 51 Insider · 33 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Stuart Essig | President and CEO | 1. Juni 2026 A | 200.000 | 0 | 0 | $0 |
| Mojdeh Poul | President & CEO | 11. März 2026 A | 0 | 0 | 0 | $0 |
| Jan De Witte | President & CEO | 1. November 2024 M | 23.902 | 0 | 0 | $0 |
| Peter J Arduini | President & CEO | 3. September 2021 M | 216.713 | 0 | 0 | $0 |
| Lea Daniels Knight | EVP & Chief Financial Officer | 3. Juli 2026 F | 45.263 | 0 | 0 | $0 |
| Carrie L Anderson | Executive Vice President & CFO | 1. Juli 2022 F | 57.811 | 0 | 0 | $0 |
| Maureen B Bellantoni | Executive VP, CFO | 2. April 2007 A | 4.366 | 0 | 0 | $0 |
| Glenn Coleman | Executive Vice President & COO | 1. Juli 2022 F | 34.622 | 0 | 0 | $0 |
| Gerard S Carlozzi | Executive Vice President & COO | 1. April 2010 A | 10.713 | 0 | 0 | $0 |
| Chantal Veillon-Berteloot | EVP & CHRO | 1. September 2026 F | 20.772 | 0 | 0 | $0 |
| Harvinder Singh | EVP & President, SS | 1. Juli 2026 A | 35.422 | 0 | 0 | $0 |
| Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | 1. Juli 2026 F | 34.516 | 0 | 0 | $0 |
| Robert T. Davis JR. | EVP & President, TR&DT | 1. Juli 2026 A | 66.387 | 0 | 0 | $0 |
| Michael J. Mcbreen | EVP & Chief Commercial Officer | 1. Juni 2026 A | 60.743 | 0 | 0 | $0 |
| Michael David Hutchinson | EVP, Chief Legal Officer & Sec | 11. März 2026 A | · | 0 | 0 | $0 |
| Eric Schwartz | EVP, Chief Legal Officer & Sec | 11. März 2025 F | 56.020 | 0 | 0 | $0 |
| Lisa Evoli | EVP & CHRO | 10. März 2023 A | 18.446 | 0 | 0 | $0 |
| Daniel L. Reuvers | CVP,PRES - CODMAN SPC SURGICAL | 11. Mai 2020 M | 42.473 | 0 | 0 | $0 |
| Kenneth Burhop | CORPVP,CHIEFSCIENTIFIC OFFICER | 13. Februar 2020 A | 15.100 | 0 | 0 | $0 |
| John Mooradian | Corp VP, Global Ops & Supp Chn | 13. Februar 2020 A | 17.542 | 0 | 0 | $0 |
| Judith Ogrady | CorpVP,Global Reg.Affairs | 13. Februar 2020 A | 24.276 | 0 | 0 | $0 |
| Joseph Vinhais | Corp VP,Quality&Transformation | 11. September 2019 S | 8.231 | 0 | 0 | $0 |
| Richard D. Gorelick | Corp VP, Gen Counsel & Sec | 23. März 2018 F | 25.752 | 0 | 0 | $0 |
| Mark A Augusti | CVP,PRES-ORTHO & TISSUE TECH | 7. Oktober 2016 F | 7.962 | 0 | 0 | $0 |
| Deborah A Leonetti | Corp VP, Glbl Servs & Repair | 8. Mai 2015 S | 8.715 | 0 | 0 | $0 |
| Padma Thiruvengadam | Corp VP, Chief HR Officer | 2. April 2015 F | 10.229 | 0 | 0 | $0 |
| Brian Larkin | Corp VP, Pres.Gbl Spine &Ortho | 2. April 2015 F | 6.682 | 0 | 0 | $0 |
| John B Henneman III | CorpVP, CAO | 25. August 2014 S | 34.159 | 0 | 0 | $0 |
| Jerry E Corbin | Corp VP & Corporate Controller | 1. Juli 2014 F | 7.549 | 0 | 0 | $0 |
| Robert D Paltridge | Corp VP, Pres. Adv Woundcare | 1. Juli 2014 F | 34.480 | 0 | 0 | $0 |
| David B Holtz | Senior VP, Finance (1) | 31. Dezember 2006 F | 16.374 | 0 | 0 | $0 |
| Don R Nociolo | Senior VP, Operations | 15. März 2006 S | 18.984 | 0 | 0 | $0 |
| Michael Piershbacher | Senior V.P.., R&D | 3. März 2004 S | 0 | 0 | 0 | $0 |
| Renee Wonlai Lo | Direktor | 7. Mai 2026 A | 35.743 | 0 | 0 | $0 |
| Shaundra Clay | Direktor | 7. Mai 2026 A | 41.515 | 0 | 0 | $0 |
| Christian S Schade | Direktor | 7. Mai 2026 A | 90.034 | 0 | 0 | $0 |
| Keith Bradley | Direktor | 7. Mai 2026 A | 88.254 | 0 | 0 | $0 |
| Raymond G. Murphy | Direktor | 9. Mai 2024 A | 54.007 | 0 | 0 | $0 |
| Donald E Morel JR | Direktor | 13. Mai 2022 A | 55.753 | 0 | 0 | $0 |
| Rhonda Germany Ballintyn | Direktor | 14. Mai 2021 A | 17.162 | 0 | 0 | $0 |
| Lloyd Howell JR | Direktor | 13. Mai 2020 A | 44.638 | 0 | 0 | $0 |
| James M Sullivan | Direktor | 17. Mai 2018 A | 62.569 | 0 | 0 | $0 |
| Neal Moszkowski | Direktor | 22. Mai 2013 A | 6.936 | 0 | 0 | $0 |
| Thomas J Baltimore Jr | Direktor | 17. Mai 2012 A | 22.727 | 0 | 0 | $0 |
| Anne Vanlent | Direktor | 17. Mai 2012 A | 8.478 | 0 | 0 | $0 |
| David C Auth | Direktor | 17. Mai 2005 A | · | 0 | 0 | $0 |
| Tru St Partnership, L.P. | 10%-Eigentümer | 23. März 2022 S | 8.515.930 | 0 | 0 | $0 |
| Richard E Caruso | 10%-Eigentümer | 18. Juni 2020 S | 10.291.205 | 0 | 0 | $0 |
| SOROS GEORGE | 10%-Eigentümer | 21. November 2005 S | 2.725.300 | 0 | 0 | $0 |
| Jeffrey A Graves | · | 7. Mai 2026 A | 41.086 | 1 | 0 | $102.150 |
| Barbara B Hill | · | 7. Mai 2026 A | 151.191 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 45 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,12% | 46.382 NS | 31. Juli 2026 | N-PORT |
| IBRN · iShares Trust | 1,09% | 5.220 SH | 11. September 2026 | Täglich |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,58% | 63.698 SH | 1. Oktober 2026 | Täglich |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 7.084 SH | 1. Oktober 2026 | Täglich |
| ESSC · Strategy Shares | 0,19% | 4.086 NS | 31. Juli 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,16% | 76.361 SH | 19. August 2026 | Täglich |
| IHI · iShares Trust | 0,16% | 319.452 SH | 11. September 2026 | Täglich |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,13% | 141.969 SH | 19. August 2026 | Täglich |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,11% | 128.406 SH | 1. Oktober 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 58.920 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,07% | 123.322 SH | 1. Oktober 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,07% | 10.513 SH | 1. Oktober 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,07% | 342.338 NS | 31. Juli 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,06% | 233.273 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 393.933 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,04% | 32.704 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.748.403 SH | 11. September 2026 | Täglich |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 960.851 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 198.881 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 32.504 NS | 31. Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,01% | 102.070 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 15.062 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 769.716 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,01% | 1.512.318 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 4.261 SH | 11. September 2026 | Täglich |
| SMDX · Tidal Trust III | 0,01% | 610 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 70.522 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1.004 SH | 1. Oktober 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 1.247 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 81.918 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 19.275 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3.400 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.399 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 25.248 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 91.548 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 19.842 SH | 11. September 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,00% | 1.313 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.108.295 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.829 SH | 19. August 2026 | Täglich |
| IJR · iShares Trust | · | 4.077.904 SH | 10. September 2026 | Täglich |
| IJS · iShares Trust | · | 599.789 SH | 8. September 2026 | Täglich |
| IWN · iShares Trust | · | 642.111 SH | 11. September 2026 | Täglich |
| XJR · iShares Trust | · | 9.216 SH | 31. August 2026 | Täglich |
| ISCB · iShares Trust | · | 2.961 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 14.538 SH | 11. September 2026 | Täglich |
IART Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$19.00
+49,8%
4 22,2%
Starker Kauf
4 22,2%
Kauf
8 44,4%
Halten
2 11,1%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
9 Analysten · 2026-09-29Mittelwert-Ziel $19.56 +54,2%
← Unter allen Zielen
Aktueller Preis $12.68
Tief$14.00
Mittelwert$19.56
Hoch$27.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IART | · | -1.8 | 1.5% | -31.6% | -49.6% | · |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| CBLL | $822M | -15.0 | 36.1% | -60.0% | -32.6% | 87.9% |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| AVR | $207M | -2.0 | -29.2% | -4921.3% | -300.5% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 29, 2026